J0693 HCPCS Level II Code: Injection, cefiderocol, 5 mg
Medicare Coverage & Payment
- CMS short descriptor: Inj., cefiderocol, 5 mg
- Medicare coverage: Carrier judgment (CMS coverage code C)
- Payment category: Drugs (pricing indicator 51)
- BETOS: O1E — Other drugs
- Last CMS action effective: October 1, 2021
- Terminated: September 30, 2021
Source: CMS HCPCS Level II release. Coverage codes indicate how Medicare treats the code, not whether a specific claim will be paid; payer policy and documentation still govern.
Code Set: Removed from the code set — not valid on or after October 1, 2021.
Contextual Map
Every relationship of J0693 in one view: hierarchy, official tabular instructions in both directions, clinical classification, risk adjustment, MS-DRG participation, index terms and change history — each edge carrying the CMS source it derives from.
Nearest codes (40)
- J0608 — Lanthanum carbonate, oral, powder, 5 mg, not therapeutically equivalent to j0607 (for esrd on dialysis)[Sibling]— CMS HCPCS Level II code set
- J0609 — Ferric citrate, oral, 3 mg ferric iron, (for esrd on dialysis)[Sibling]— CMS HCPCS Level II code set
- J0610 — Injection, calcium gluconate (fresenius kabi), per 10 ml[Sibling]— CMS HCPCS Level II code set
- J0611 — Injection, calcium gluconate (wg critical care), per 10 ml[Sibling]— CMS HCPCS Level II code set
- J0612 — Injection, calcium gluconate, not otherwise specified, 10 mg[Sibling]— CMS HCPCS Level II code set
- J0613 — Injection, calcium gluconate (wg critical care), not therapeutically equivalent to j0612, 10 mg[Sibling]— CMS HCPCS Level II code set
- J0614 — Injection, treosulfan, 50 mg[Sibling]— CMS HCPCS Level II code set
- J0615 — Calcium acetate, oral, 23 mg (for esrd on dialysis)[Sibling]— CMS HCPCS Level II code set
- and 32 more
Change history (2)
- October 1, 2021 — Removed from the code set [Change history]— CMS release files (code change ledger)
- and 1 more
Sources for this page
Codes, titles, notes, index terms and mappings on this page are transcribed from the datasets below. Relationships MedCoder computed and text MedCoder wrote are labelled where they appear.
- Code, descriptors, coverage and pricing attributes Official source data
- CMS HCPCS Alpha-Numeric (ANWEB) release — July 2026 quarterly update Release, file and checksum · Publisher’s page
- Change history and date-of-service validity Official source data
- CMS HCPCS quarterly update files, ingested into the change ledger Release, file and checksum · Publisher’s page
- Comparisons, relationships and the contextual map MedCoder structured relationship
- Computed by MedCoder from the tabular notes and tables above; every derived relationship is marked as derived where it appears
- Summary and FAQ answers MedCoder explanation
- Written by MedCoder to explain the sources above: drafted with AI assistance, checked by a person against the release files, and labelled as MedCoder text where it appears. Not official text.
Labels on this page: Official source data · MedCoder structured relationship · MedCoder explanation. How to read the labels · All data sources and release dates
Change history
- October 1, 2021Removed from the code setInjection, cefiderocol, 5 mg
- January 1, 2021Added to the code setInjection, cefiderocol, 5 mg
Nearest Codes in This Family
Official HCPCS Level II classifications closest to J0693 in its code family, with their registry titles.
- J0688 — Injection, cefazolin sodium (hikma), not therapeutically equivalent to j0690, 500 mg
- J0689 — Injection, cefazolin sodium (baxter), not therapeutically equivalent to j0690, 500 mg
- J0690 — Injection, cefazolin sodium, 500 mg
- J0691 — Injection, lefamulin, 1 mg
- J0692 — Injection, cefepime hydrochloride, 500 mg
- J0694 — Injection, cefoxitin sodium, 1 gm
- J0695 — Injection, ceftolozane 50 mg and tazobactam 25 mg
- J0696 — Injection, ceftriaxone sodium, per 250 mg
- J0697 — Injection, sterile cefuroxime sodium, per 750 mg
- J0698 — Injection, cefotaxime sodium, per gm